HLS THERAPEUTICS INC.

Research HLS THERAPEUTICS INC. (74D) on Bullrun: market cap EUR 80.06M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker74D
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 80.06M
• Financial periodQ4 2025
• RevenueEUR 15.20M
• Net income-EUR 1.34M
• Free cash flowEUR 6.19M
• Gross margin82.6%

Valuation Snapshot

latest market cap is EUR 80.06M.

About HLS THERAPEUTICS INC.

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozaril;

Frequently asked questions

What is HLS THERAPEUTICS INC.'s market cap?

HLS THERAPEUTICS INC.'s market capitalization is EUR 80.06M.

What does HLS THERAPEUTICS INC. do?

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.